期刊
CLINICAL NUCLEAR MEDICINE
卷 48, 期 3, 页码 278-279出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000004488
关键词
myeloid sarcoma; F-18-FDG; fibroblast activation protein; Ga-68-FAPI; PET/CT
A 28-year-old woman presented with a 2-month history of chest wall swelling and pain. Chest CT revealed an irregular soft tissue mass in the chest wall and mediastinum. F-18-FDG PET/CT showed significant FDG uptake in the mass. Subsequently, the patient participated in a Ga-68-DOTA-FAPI-04 PET/CT tumor clinical trial, which also showed elevated tracer uptake in the mass. Biopsy confirmed a diagnosis of myeloid sarcoma.
A 28-year-old woman presented with a 2-month history of swelling and pain in the chest wall. An irregular soft tissue mass in the chest wall and mediastinum was showed on chest CT. F-18-FDG PET/CT revealed obvious FDG uptake in the mass. Subsequently, the patient was participated in a Ga-68-DOTA-FAPI-04 PET/CT tumor clinical trial. Ga-68-DOTA-FAPI-04 PET/CT also showed elevated tracer uptake in the mass. Biopsy of the mass confirmed a diagnosis of myeloid sarcoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据